A detailed history of Rothschild Investment LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 16 shares of CRL stock, worth $3,446. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16
Previous 17 5.88%
Holding current value
$3,446
Previous $3.51 Million 10.25%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$187.96 - $245.29 $187 - $245
-1 Reduced 5.88%
16 $3.15 Million
Q2 2024

Jul 30, 2024

BUY
$206.39 - $268.73 $3,508 - $4,568
17 New
17 $3.51 Million
Q1 2024

Jul 31, 2024

BUY
$203.52 - $273.43 $407 - $546
2 Added 22.22%
11 $2.98 Million
Q4 2023

Jul 31, 2024

SELL
$164.52 - $238.84 $1,316 - $1,910
-8 Reduced 47.06%
9 $2.13 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $11B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.